Pharmacies in Frogn: Companies, Statistics, and Outlook

Pharmacies in Frogn constitute a stable but dynamic sector with a focus on Drøbak. In 2026, there are four pharmacies registered in the municipality, with a total of 48 employees. In recent years, the sector has shown both strong growth and periods of decline, particularly in 2017 when sales fell to zero. Today, there is a clear increase in sales and number of employees, although there was a decline in 2025. The most dominant activity takes place in Drøbak, which has three pharmacies and 49 employees. This shows that Drøbak is an important central point for pharmacy activity in Frogn.

Sales and employees in the pharmacy sector

Sales (NOK):

• 2016: 40.2 million
• 2017: 0 (largest decline)
• 2022: 116.0 million
• 2024: 155.3 million
• 2025: 137.7 million

Employees:

• 2016: 23
• 2020: 48
• 2022: 54
• 2023: 58
• 2026: 48

Sales experienced a sharp decline in 2017, but have since grown with an average annual growth of approximately 15% from 2018 to 2024. The number of employees has grown until 2023, but has subsequently decreased. This may be due to variations in operations and competitiveness among pharmacies.

Registered companies in the pharmacy sector

The following companies are registered in Frogn:

Most companies are AS (limited liability companies), and there is a clear dominance of pharmacies in Drøbak. One of the companies has an organizational form as KBO (bankruptcy estate), but it is not registered as bankruptcy in the data.

Geographic distribution of the activity

Drøbak is the only place in Frogn with registered pharmacy activities. Here you will find:

• 3 pharmacies
• 49 employees
• Sales of 116.0 million NOK (2022)
• EBITDA of 8.5 million NOK

Drøbak is therefore the most important geographic center for pharmacy activity in Frogn. There is a clear concentration of pharmacies in this area, which may be due to population density and infrastructure.

• Bankruptcy: One company with organizational form KBO (bankruptcy estate) is registered, but it is not registered as bankruptcy in the data.
• Operational results: Most companies have positive EBITDA (7% margin) and high sales growth (10% annual average).
• Stability: Although there has been a decline in the number of employees in 2025, there are no clear signs of systematic decline in the sector. Most companies have stable operations and positive EBITDA.

There are no clear signs of major operational instability or bankruptcy in the sector, even though there is a company form as KBO registered.

• Stable market: The pharmacy sector in Frogn has shown stable growth in sales and number of employees since 2018, with an average annual growth of approximately 15%.
• Concentration in Drøbak: There is a clear concentration of pharmacies in Drøbak, which may provide opportunities for cooperation or specialization in this area.
• Competitiveness: The existing companies have a high EBITDA margin (7%) and positive operations, which indicates that the sector is competitive.
• Possible challenges: The decline in 2025 (sales and employees) should be considered, but there are no clear signs of systematic decline in the sector.

For entrepreneurs, this can be an opportunity to establish themselves in a stable but competitive sector with a focus on Drøbak.

The pharmacy sector in Frogn shows a mix of stability and dynamism. With a clear concentration in Drøbak and growth in sales and number of employees since 2018, it is an attractive sector for entrepreneurs. At the same time, it is important to be aware of the periodic variations in operations and competitiveness. SmartGrunder can help entrepreneurs find suitable addresses and develop strategies to establish themselves in this sector.